UBS Group’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.36M | Buy |
572,735
+94,305
| +20% | +$719K | ﹤0.01% | 3179 |
|
|
2025
Q1 | $1.56M | Buy |
478,430
+145,270
| +44% | +$474K | ﹤0.01% | 3864 |
|
|
2024
Q4 | $1.5M | Buy |
333,160
+191,895
| +136% | +$864K | ﹤0.01% | 3932 |
|
|
2024
Q3 | $391K | Buy |
141,265
+44,893
| +47% | +$124K | ﹤0.01% | 4254 |
|
|
2024
Q2 | $330K | Buy |
96,372
+33,236
| +53% | +$114K | ﹤0.01% | 4217 |
|
|
2024
Q1 | $342K | Buy |
63,136
+43,148
| +216% | +$234K | ﹤0.01% | 4351 |
|
|
2023
Q4 | $108K | Buy |
19,988
+16,997
| +568% | +$92.1K | ﹤0.01% | 4939 |
|
|
2023
Q3 | $26.3K | Buy |
+2,991
| New | +$26.3K | ﹤0.01% | 5525 |
|